Client Highlight: Kite Pharma

Client Highlight: Kite Pharma

S&C client Kite Pharma announces $11.9 billion acquisition by Gilead Sciences.

S&C represents Kite Pharma, Inc. in its acquisition by Gilead Sciences, Inc. for $180.00 per share in cash in a transaction valued at approximately $11.9 billion.